4//SEC Filing
Moat Ross 4
Accession 0001415889-25-023874
CIK 0001730430other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:37 PM ET
Size
4.9 KB
Accession
0001415889-25-023874
Insider Transaction Report
Form 4
Moat Ross
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Class A Ordinary Share
2025-09-04$35.31/sh−3,523$124,397→ 9,415 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001857177
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:37 PM ET
- Size
- 4.9 KB